Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study

Patients with immune thrombocytopenia (ITP) may respond to one thrombopoietin receptor agonist (TPO‐RA) but not another. Limited data are available describing outcomes in patients who switched from romiplostim or eltrombopag to avatrombopag, a newer oral TPO‐RA. We performed a retrospective observat...

Descripción completa

Detalles Bibliográficos
Autores principales: Al‐Samkari, Hanny, Jiang, Debbie, Gernsheimer, Terry, Liebman, Howard, Lee, Susie, Wojdyla, Matthew, Vredenburg, Michael, Cuker, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Platelets, Thrombosis and Haemostasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306832/
https://www.ncbi.nlm.nih.gov/pubmed/35179784
http://dx.doi.org/10.1111/bjh.18081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306832/
https://www.ncbi.nlm.nih.gov/pubmed/35179784
http://dx.doi.org/10.1111/bjh.18081

Ejemplares similares